Close Asset Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $3.94M | Sell |
140,350
-8,270
| -6% | -$220K | 0.11% | 58 |
|
|
2025
Q4 | $3.7M | Sell |
148,620
-3,693
| -2% | -$93.1K | 0.08% | 60 |
|
|
2025
Q3 | $3.88M | Sell |
152,313
-36,259
| -19% | -$895K | 0.09% | 59 |
|
|
2025
Q2 | $4.57M | Sell |
188,572
-5,865
| -3% | -$137K | 0.13% | 57 |
|
|
2025
Q1 | $4.93M | Sell |
194,437
-20,747
| -10% | -$543K | 0.14% | 52 |
|
|
2024
Q4 | $5.71M | Hold |
215,184
| – | – | 0.16% | 49 |
|
|
2024
Q3 | $6.23M | Sell |
215,184
-1,889
| -0.9% | -$55.1K | 0.19% | 48 |
|
|
2024
Q2 | $6.08M | Sell |
217,073
-22,811
| -10% | -$628K | 0.21% | 49 |
|
|
2024
Q1 | $6.65M | Sell |
239,884
-28,040
| -10% | -$778K | 0.24% | 49 |
|
|
2023
Q4 | $7.71M | Sell |
267,924
-45,312
| -14% | -$1.37M | 0.32% | 43 |
|
|
2023
Q3 | $10.4M | Sell |
313,236
-5,513
| -2% | -$195K | 0.54% | 37 |
|
|
2023
Q2 | $11.7M | Sell |
318,749
-5,308
| -2% | -$207K | 0.55% | 34 |
|
|
2023
Q1 | $13.2M | Buy |
+324,057
| New | +$14M | 0.65% | 30 |
|
|
2022
Q2 | – | Sell |
-322,320
| Closed | -$19M | – | 213 |
|
|
2022
Q1 | $19M | Hold |
322,320
| – | – | 0.68% | 22 |
|
|
2021
Q4 | $19M | Sell |
322,320
-25,077
| -7% | -$1.24M | 0.68% | 22 |
|
|
2021
Q3 | $14.9M | Sell |
347,397
-3,333
| -1% | -$148K | 0.73% | 20 |
|
|
2021
Q2 | $13.7M | Sell |
350,730
-3,942
| -1% | -$153K | 0.66% | 23 |
|
|
2021
Q1 | $12.9M | Sell |
354,672
-2,510
| -0.7% | -$89.1K | 0.68% | 23 |
|
|
2020
Q4 | $13.1M | Buy |
357,182
+3,970
| +1% | +$146K | 0.99% | 17 |
|
|
2020
Q3 | $12.3M | Sell |
353,212
-2,822
| -0.8% | -$98.9K | 0.84% | 15 |
|
|
2020
Q2 | $11M | Buy |
356,034
+5,755
| +2% | +$196K | 0.82% | 15 |
|
|
2020
Q1 | $10.9M | Sell |
350,279
-11,615
| -3% | -$396K | 0.97% | 14 |
|
|
2019
Q4 | $13.4M | Buy |
361,894
+6,426
| +2% | +$229K | 1.05% | 15 |
|
|
2019
Q3 | $12.1M | Sell |
355,468
-18,276
| -5% | -$665K | 1.07% | 16 |
|
|
2019
Q2 | $15.4M | Buy |
373,744
+41,929
| +13% | +$1.66M | 1.2% | 15 |
|
|
2019
Q1 | $13.4M | Buy |
331,815
+316,008
| +1,999% | +$12.7M | 1.14% | 14 |
|
|
2018
Q4 | $385K | Sell |
15,807
-455,459
| -97% | -$18.9M | 0.04% | 72 |
|
|
2018
Q3 | $17.6M | Sell |
471,266
-8,592
| -2% | -$331K | 1.42% | 16 |
|
|
2018
Q2 | $15.9M | Hold |
479,858
| – | – | 1.35% | 20 |
|
|
2018
Q1 | $15.9M | Sell |
479,858
-9,336
| -2% | -$321K | 1.29% | 21 |
|
|
2017
Q4 | $16.8M | Sell |
489,194
-31,040
| -6% | -$1.06M | 1.52% | 19 |
|
|
2017
Q3 | $17.6M | Sell |
520,234
-3,283
| -0.6% | -$106K | 1.74% | 19 |
|
|
2017
Q2 | $16.7M | Sell |
523,517
-3,046
| -0.6% | -$96.1K | 1.86% | 19 |
|
|
2017
Q1 | $17.1M | Buy |
526,563
+268,223
| +104% | +$8.46M | 1.8% | 18 |
|
|
2016
Q4 | $7.96M | Buy |
+258,340
| New | +$7.89M | 1.21% | 21 |
|
Other funds holding PFE
VCM
VPM
Close Asset Management's PFE Position: Q1 2026 in Review
Close Asset Management reduced its Pfizer (PFE) stake by 5.6% in Q1 2026, selling an estimated $220K and leaving 140,350 shares worth $3.94M. The position accounts for 0.11% of the portfolio, ranked #58.
Close Asset Management first reported a position in PFE in Q4 2016 and has held it in 35 quarters since. The position peaked at $19M in Q1 2022. 2,939 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Close Asset Management held 140,350 shares of Pfizer worth $3.94M as of Q1 2026.
- Close Asset Management sold 8,270 Pfizer shares in Q1 2026, an estimated $220K.
- Pfizer made up 0.11% of Close Asset Management's portfolio in Q1 2026, its #58 holding.
- Close Asset Management first reported a position in Pfizer in Q4 2016 and has held it in 35 quarters since.
- Close Asset Management's Pfizer position peaked at $19M in Q1 2022.
- 2,939 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Close Asset Management's 13F filing for Q1 2026, filed 12 May 2026.